Gynofem Healthcare Unlisted Share
₹64▲6.67%(4.00)
About the company
Gynofem Healthcare Ltd. is a fast-growing Indian pharmaceutical company dedicated to improving women's health through specialized and innovative healthcare solutions. The company focuses on developing, manufacturing, and marketing a diverse portfolio of pharmaceutical products, with particular expertise in gynecology, fertility care, pregnancy support, and women's reproductive health. Its products are designed to address the unique healthcare needs of women at every stage of motherhood—from planning a pregnancy and conception to prenatal care, childbirth, and postnatal recovery.
Gynofem's product range supports women who are trying to conceive naturally as well as those requiring medical assistance due to fertility-related conditions. The company also offers nutritional and therapeutic solutions that help promote a healthy pregnancy, support fetal development, and aid mothers in recovering after childbirth. By focusing on quality, safety, and clinical effectiveness, Gynofem aims to make specialized women's healthcare more accessible and reliable.
Fundamentals
Valuation
Registry
| Metric | Value |
|---|---|
| PAN number | AAGCG4141F |
| ISIN number | INE0NLL01017 |
Figures in ₹ Cr ·
Financials
| P&L Statement | FY26Latest | FY25 |
|---|---|---|
| Revenue | 501.7 | 494.3 |
| EBITDA | -43.5 | -111.8 |
| OPM (%) | -8.65 | -22.62 |
| PBT | -115.5 | -179 |
| PAT | -134.9 | -209.3 |
| EPS (₹) | -0.14 | -0.21 |
Shareholding Pattern
| Holder | Percentage |
|---|---|
| Gynofem healthcare Pvt Ltd | 78.48% |
| Kalpana Mansukh Satra | 10.38% |
| Practibully Investment Services LLP | 6.66% |
| Others | 4.48% |
Leadership
Frequently asked questions
Common questions on Gynofem Healthcare Unlisted Share—tap a row to read the answer.
Q.1What does Gynofem Healthcare Ltd. do?
Gynofem Healthcare Ltd. is an Indian pharmaceutical company focused on women's healthcare. It develops and markets a range of products related to gynecology, fertility care, pregnancy support, maternal nutrition, and postnatal recovery. The company primarily serves the domestic market and aims to make specialized healthcare products accessible across both urban and rural India.
Q.2How can I buy Gynofem Healthcare Unlisted Shares?
You can purchase Gynofem Healthcare Unlisted Shares through an off-market transaction from an existing shareholder or a registered intermediary dealing in unlisted securities. Once the required documentation, payment, and verification are completed, the shares are transferred electronically to your Demat account.
Q.3How is the Gynofem Healthcare Unlisted Share Price determined?
Unlike listed stocks, unlisted shares are not traded on stock exchanges. Their price is generally determined by factors such as the company's financial performance, business growth, market demand, recent private transactions, industry outlook, and overall investor interest. Since there is no live market price, valuations may differ between transactions.
Q.4Is Gynofem Healthcare a good long-term investment?
The suitability of any investment depends on your financial goals and risk tolerance. Before investing in Gynofem Healthcare Unlisted Shares, consider the company's business model, financial performance, management quality, industry outlook, profitability, and future growth potential. Conducting thorough research helps you make a more informed investment decision.
Q.5Can I sell Gynofem Healthcare Unlisted Shares whenever I want?
Yes, unlisted shares can generally be sold through private off-market transactions. However, unlike listed stocks, selling depends on finding a willing buyer. As a result, the time required to complete a transaction may vary based on market demand and liquidity.
Q.6Does Gynofem Healthcare have plans for an IPO?
Any future IPO plans depend entirely on the company's strategic decisions and regulatory approvals. Investors should rely on official company announcements for the latest information rather than market speculation.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Top 10 Unlisted Shares in India in 2026: Companies, Fundamentals & What Investors Should Know
Explore 10 unlisted shares in India in 2026, including MSEI, Garuda Aerospace, OYO, Goodluck Defence, 63SATS, NCDEX, API Holdings and more.

Unlisted Share Price List India — Buy and sell Pre-IPO Shares
Unlisted shares pertain to equity shares which are not listed on recognized stock exchanges. This guide explains the mechanics of unlisted shares, the process by which an investor can purchase them, the method of valuation and red flags which should be noted by an investor prior to buying unlisted shares. The article also highlights the differences between listed, unlisted, and pre-IPO shares while discussing the risks such as low liquidity, valuation, business, and IPO risk. The article provides a checklist and frequently asked questions to understand the nuances of unlisted shares.

MSEI, Zepto and Other Pre-IPO Shares Move: 2026 Performance
MSEI surged over 124% while Zepto declined nearly 48% in 2026. Explore how other pre-IPO and unlisted shares performed and what the latest market trends mean for investors.

Sagar Defence Unlisted Share: Price, Financials & Why Investors Are Watching This Defence-Tech Stock
Sagar Defence Engineering's unlisted shares are drawing attention as India's defence-tech push gains momentum. Here's a look at the company, its FY26 numbers, and what to know before investing.

API Holdings & MSEI Unlisted Shares Surge: What’s Driving the Rally?
API Holdings and MSEI unlisted shares are witnessing sharp price movements, attracting fresh investor attention. Discover what is driving the rally, the latest trends and key factors to consider before investing.

NSE IPO Price Band vs NSE Unlisted Share Price — What Is the Difference?
The upcoming NSE IPO has created strong interest around the difference between the -NSE IPO price band and NSE unlisted share price. Recent reports indicate a possible IPO price range of ₹1,700–₹1,785, while NSE unlisted shares were around ₹2,045 on 9 September 2026. This blog explains why these prices can differ and covers NSE’s latest financial performance, valuation, IPO structure, lock-in period, business strengths and key risks investors should understand before evaluating NSE shares.
